OIS@ASCRS 2016

Summit Kick Off with Ophthalmology Innovation Cycle & Financing Update

By Tom Salemi | June 17, 2016

OIS Co-Chair Bill Link of Versant Ventures welcomes attendees to OIS@ASCRS 2016 with a history of how the Ophthalmology Innovation Summits started, where they’re headed…

Read More

State of the Premium Channel Market

By Michael Lachman | June 4, 2016

By Michael Lachman The cataract surgery premium channel consists primarily of presbyopia-correcting intraocular lenses (PC-IOLs), toric IOLs that correct astigmatism, and femtosecond-laser assisted cataract surgery…

Read More

Avedro Plots Future of Corneal Cross-Linking

By Mario Admin | June 3, 2016

Just about two weeks after getting Food and Drug Administration (FDA) clearance for its corneal crosslinking platform, Avedro Chief Medical Officer Rajesh K. Raipal, MD,…

Read More
On-Sight Interview: Shire’s Dempsey Shares Strategy to Building a Brand in Ophthalmology - OIS@ASCRS - Healthegy

Shire’s Dempsey Shares Strategy to Building a Brand in Ophthalmology

By Tom Salemi | June 3, 2016

Robert Dempsey, Vice President and Business Unit Head of Ophthalmology, Shire. See below for the Video Timestamp: 00:30 – How do you build a brand…

Read More

Alcon Looking at looking at EDOF and IOL Technology

By Mario Admin | June 2, 2016

Michael Onuscheck, global surgical franchise head for Alcon, a Novartis company, outlined the firm’s approach to innovation within the premium channel, which involves both internal…

Read More

Abbott Medical Optics Points to Leadership Position

By Mario Admin | June 1, 2016

Over the past year, Abbott Medical Optics (AMO) has established a leading share position in the US PC-IOL market, driven by the new low-add-power Tecnis…

Read More

Bausch + Lomb Highlights Leadership in IOLs

By Mario Admin | May 31, 2016

Bausch + Lomb, a Valeant Pharmaceuticals company, remains the only firm with an FDA-approved accommodating IOL, the Crystalens AO. Andrew Chang, general manager and senior…

Read More

Zeiss CEO Monz on Building a Really Strong Brand

By Mario Admin | May 31, 2016

[creativ_media type=”vimeo” url=”https://vimeo.com/168647895″] Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, shares how his company’s long history in ophthalmology helps it pave…

Read More

Tom Frinzi’s Plans for AMO & Ophthalmology

By Mario Admin | May 30, 2016

Ophthalmology veteran Tom Frinzi joins OISTV to share his reasons for joining Abbott Medical Optics and what the company may be planning in coming years.…

Read More

Meury Discusses Life After Pfizer Deal

By Mario Admin | May 30, 2016

The termination of the Pfizer-Allergan merger actually left some in ophthalmology feeling relief. We ask Bill Meury of Allergan how did Allergan employees feel about…

Read More

Eye Care Priority for J&J

By Mario Admin | May 30, 2016

Ashley McEvoy, Company Chair of Vision Care and Diabetes at Johnson & Johnson, joins OISTV to discuss Johnson & Johnson’s commitment to eye health. Video…

Read More

B&L’s Roberts Still Thinks Like a Doctor

By Mario Admin | May 30, 2016

Calvin Roberts, MD, CMO at Bausch & Lomb lends his physician’s perspective to how companies like Bausch & Lomb can serve eye care. Video Highlights…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.